Dobutamine-induced ST segment elevation and ventricular fibrillation with nonsignificant coronary artery disease
- 30 November 1996
- journal article
- case report
- Published by Elsevier in American Heart Journal
- Vol. 132 (5) , 1058-1060
- https://doi.org/10.1016/s0002-8703(96)90025-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Complication of dobutamine stress echocardiographyThe Lancet, 1995
- Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery diseaseThe American Journal of Cardiology, 1994
- Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery diseaseThe American Journal of Cardiology, 1993
- Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients.Circulation, 1993
- Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular diseaseJournal of the American College of Cardiology, 1993
- Prognostic value of dobutamine echocardiography in patients with high pretest likelihood of coronary artery diseaseThe American Journal of Cardiology, 1993
- New developments in pharmacologic stress imagingAmerican Heart Journal, 1992
- Dobutamine-induced ST segment elevation in a patient with angina at rest and critical coronary lesionsEuropean Heart Journal, 1992
- Dobutamine digital echocardiography for detecting coronary artery diseaseThe American Journal of Cardiology, 1991